Skip to main content
. 2021 May 7;27(17):2025–2038. doi: 10.3748/wjg.v27.i17.2025

Table 3.

Multivariate analysis of factors associated with hepatitis B-related cirrhosis progression to hepatocellular carcinoma in nucleos(t)ide analog-treated patients

Risk factor
β
SE
Wald
P value
OR (95%CI)
Age ≥ 60 yr 1.127 0.390 8.347 0.004 3.089 (1.437-6.631)
Smoking history 1.387 0.397 12.180 < 0.01 4.001 (1.836-8.716)
Family history of HBV-related HCC 1.911 0.860 4.938 < 0.05 6.763 (1.253-36.499)
LAM resistance 1.082 0.456 5.638 0.018 2.949 (1.207-7.208)
HBV DNA negative -3.479 0.816 19.427 < 0.01 0.026 (0.007-0.139)
FBG ≥ 6.16 mmol/L 1.977 0.339 34.030 < 0.01 7.219 (3.716-14.024)

CI: Confidence interval; FBG: Fasting blood glucose; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; LAM: Lamivudine OR: Odds ratio;; SE: Standard error.